Sandoz is offering a generic paclitaxel formulation, which is the first FDA-approved ANDA to BioScience’s Abraxane for ...

【引用本文】王 权，李 爽. 免疫治疗时代Ⅳ期胃癌转化治疗方案选择[J]. 中国实用外科杂志,2024,44(10):1129-1133.  摘要 ...

接种癌症疫苗的本质在于激活人体免疫系统，使之精准识别并有效攻击癌细胞。该疗法的首要目标是控制肿瘤的生长，预防其复发或转移，并强化免疫系统识别和清除癌细胞的能力。癌症疫苗的作用机理在于诱发针对特定肿瘤相关抗原（TAA，即由癌细胞表达的独特蛋白质）的免疫 ...

The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...

Discordance Between the Initial Diagnosis of Sarcomas and Subsequent Histopathological Revision and Molecular Analyses in a Sarcoma Reference Center in Brazil This study involved 3,708 patients with ...

Th e GINECO trial explored the combination of trastuzumab with paclitaxel and carboplatin in patients with resistant AOC (< 6 months) and HER2 gene amplification. Patients and Methods: A total of ...

From a casual observer to a cancer campaigner, Diane Coetzer shares her insights on the physical and emotional challenges of ...

- Announced Positive Initial Data, Including Complete and Partial Responses, with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients - - Granted FDA Orphan Drug ...